GlassScriptPhysician profile
William C Mayfield
NPI 1568435808
$3,294.71
in general payments reported to CMS, 2019-2025
29 companies · $752 in 2025
The $752 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $904 · 2020: $219 · 2021: $559 · 2022: $422 · 2023: $296 · 2024: $144 · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599 · Travel and Lodging: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.83 |
| Travel and Lodging | $593.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $593.28 | 2025 | |
| Ferring Pharmaceuticals INC. | $559.67 | 2019-2025 | Euflexxa |
| Smith+Nephew, INC. | $418.21 | 2019-2023 | Stravix |
| Zimmer Biomet Holdings, INC. | $258.73 | 2021-2024 | Gel-One Cross-Linked Hyaluronate |
| Alpha Orthopedic Systems | $222.99 | 2019 | |
| Amgen INC. | $167.79 | 2019-2023 | Evenity, Prolia |
| Stryker Corporation | $164.35 | 2019-2022 | |
| Pacira Therapeutics, INC. | $164.17 | 2019-2021 | |
| Radius Health, INC. | $113.53 | 2019-2021 | |
| Theragen, INC. | $57.66 | 2022-2024 | Actastim-S |
| Orthogenrx INC. | $56.24 | 2019 | |
| Djo, LLC | $48.91 | 2021-2023 | Cmf |
| Skeletal Dynamics INC | $47.25 | 2019 | |
| Depuy Synthes Sales INC. | $46.32 | 2019-2025 | Orthovisc, Monovisc |
| Music City Medical Technologies, LLC | $40.55 | 2024-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $39.77 | 2022-2023 | Seglentis |
| Abbott Laboratories | $33.79 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $31.74 | 2022 | |
| Orthofix Medical, INC. | $31.63 | 2019-2020 | |
| Augmedics INC. | $29.25 | 2022 | |
| Fidia Pharma USA INC. | $26.74 | 2025 | Hymovis |
| Arteriocyte Medical Systems, INC. | $26.34 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $21.00 | 2019 | |
| Heraeus Medical, LLC. | $20.40 | 2021 | |
| Avanos Medical | $19.21 | 2021 | |
| Glaxosmithkline, LLC. | $16.26 | 2021 | |
| Kci USA, INC. | $14.02 | 2022 | |
| Bioventus LLC | $12.84 | 2020 | |
| Medtronic USA, INC. | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mayfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.